Skip to main content
CG
NASDAQ Finance

Carlyle, PAI Agree to Sell Women's Health Firm Theramex to Cinven

Tom Rudovsky · Reported by Reuters
More coverage: Asset Management Stocks · Financial
Sentiment info
Positive
Importance info
7
Price
$41.06
Mkt Cap
$14.631B
52W Low
$35.41
52W High
$67.3
52W Position info
16% above low
Off High info
39% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CG sits 16% above its 52-week low of $35.41.

Summary

Carlyle and PAI Partners agreed to sell specialty pharma company Theramex to rival buyout firm Cinven. Terms weren't disclosed, but the Financial Times reported the deal at €2.6 billion ($2.9 billion). Theramex focuses on women's health — menopause, osteoporosis, contraception, uterine health and fertility — and CEO Robert Stewart said Cinven is the right partner to push for global leadership in the category. For Carlyle this is a realized exit from a portfolio holding, and the reported price is a modest slice of its book rather than a thesis-changing sum. It follows a run of Carlyle deal activity this fall, including the BauWatch acquisition with CVC and the Parallax energy buy, while the Lukoil international assets deal expired in October.

At the time of this announcement, CG was trading at $41.06 on NASDAQ in the Finance sector, with a market capitalization of approximately $14.6B. The 52-week trading range was $35.41 to $67.30. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CG - Latest Insights

CG
Nov 06, 2026, 4:24 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $39.70
Real-time Price: $38.20 info
Change: -$1.50 (-4%) info
Market Cap: $13.52B info
CG
Nov 05, 2026, 6:29 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $39.50
Real-time Price: $38.20 info
Change: -$1.30 (-3%) info
Market Cap: $13.52B info
CG
Nov 05, 2026, 1:04 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $39.73
Real-time Price: $38.20 info
Change: -$1.53 (-4%) info
Market Cap: $13.52B info
CG
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $41.99
Real-time Price: $38.20 info
Change: -$3.79 (-9%) info
Market Cap: $13.52B info
CG
Nov 04, 2026, 5:47 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.55
Real-time Price: $38.20 info
Change: -$3.35 (-8%) info
Market Cap: $13.52B info